Invitrogen, Viropro, Avista Capital Holdings L.P. deal

IVGN and VPRO will combine VPRO’s protein production technology with IVGN’s PD Direct media and cell line development technology to develop a technology for manufacturing MAbs. VPRO will own the resulting technology. Further terms were not disclosed. ...